Highest-materiality recent filing
Talkspace stockholders vote 73.48% to approve UHS acquisition; advisory compensation not approved
Approved merger with Universal Health Services (UHS) via 73.48% of outstanding shares voted in favor.
Universal Health Services to acquire Talkspace for $5.25 per share, ~$835M enterprise value
Talkspace generated $229M revenue in 2025; ~6,000 providers, over 1.6M therapy sessions.
Talkspace acquired by Universal Health Services for $5.25 per share in cash
Talkspace (TALK) enters definitive merger agreement with UHS (UHS); all outstanding shares converted to $5.25 cash.
Talkspace Q4 revenue $63M (+29% YoY), net income $4.8M; FY25 EBITDA up 127% to $15.8M
Q4 revenue $63.0M (+29% YoY), net income $4.8M, adjusted EBITDA $6.6M (+147% YoY).
Talkspace presents at JPMorgan Healthcare Conference; no financial details disclosed in filing
Investor presentation furnished as Exhibit 99.1; presented at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026.
Talkspace Q3 revenue $59.4M (+25% YoY); raises FY 2025 revenue guidance to $226-230M
Revenue of $59.4M, up 25% YoY; Payor revenue grew 42% YoY while Consumer revenue fell 23%.
Talkspace acquires AI-powered peer support platform Wisdo Health
Wisdo Health is a clinically-proven AI-powered social health and peer support platform.
Talkspace Q2 revenue $54.3M (+18% YoY); adjusted EBITDA $2.3M; guides FY $220-235M
Revenue $54.3M, up 18% YoY; Payor revenue +35%, Consumer revenue -32%.
Talkspace annual meeting elects three Class I directors, ratifies auditor, approves say-on-pay
Jon Cohen elected with 77.7M for / 2.4M withheld; Erez Shachar 50.1M for / 30.0M withheld; Madhu Pawar 75.4M for / 4.7M withheld.
Talkspace Q1 2025 revenue $52.2M (+15% YoY); net income $0.3M vs ($1.5M) loss
Revenue $52.2M (+15% YoY) driven by 33% Payor revenue growth; Consumer revenue down 32%.
Talkspace Q4 revenue up 15% to $48.7M; net income $1.2M; guides 2025 rev $220M-$235M
Full-year 2024 revenue $187.6M (+25% YoY); net income $1.1M vs $(19.2)M loss in 2023.
Talkspace presents investor deck at JP Morgan Healthcare Conference; specific numbers not available
Investor presentation furnished for 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025.
Talkspace reports Q3 2024 net income of $1.9M; revenue up 23% to $47.4M
Revenue $47.4M (+23% YoY); payor revenue +45%, DTE +17%, consumer -30%.
Talkspace Q2 revenue up 29% YoY to $46.1M; reports positive Adj. EBITDA of $1.2M
Revenue $46.1M (+29% YoY); Payor revenue up 62% YoY; DTE revenue up 20% YoY.
Talkspace annual meeting results: directors elected, auditor ratified, say-on-pay approved
Elected Douglas Braunstein (56.6M for), Swati Abbott (58.7M for), and Liat Ben-Zur (58.7M for) as Class III directors until 2027.
Talkspace appoints Ian Harris as CFO, Jennifer Fulk steps down
Jennifer Fulk steps down as CFO effective May 20, 2024; no disagreements; will assist transition.
Talkspace reports first profitable quarter, revenue up 36% YoY to $45.4M
Revenue $45.4M (+36% YoY); Payor revenue surged 92%, consumer revenue fell 29%.
Jennifer Fulk and the Company have mutually agreed that Ms. Fulk will step down from her position as Chief Financial Officer, effective as of May 20, 2024.
Effective as of May 20, 2024, the Board has appointed Ian Harris as Chief Financial Officer to succeed Ms. Fulk.
Max materiality 1.00 · Median 0.75 · Most common event earnings